Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma

MA Baertsch, EK Mai, T Hielscher, U Bertsch, HJ Salwender, M Munder, S Fuhrmann, U Dührsen, P Brossart, K Neben, J Schlenzka, C Kunz, MS Raab, J Hillengaß, A Jauch, A Seckinger, D Hose, S Luntz, Pieter Sonneveld, H LokhorstH Martin, M Goerner, M Hoffmann, HW Lindemann, H Bernhard, IW Blau, C Scheid, B Besemer, KC Weisel, M Hänel, J Dürig, H Goldschmidt

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences